KẾT QUẢ TRUNG HẠN CAN THIỆP NỘI MẠCH TẮC ĐỘNG MẠCH CHI DƯỚI MẠN TÍNH TRÊN BỆNH NHÂN ĐÁI THÁO ĐƯỜNG TYPE 2

Abstract

Background: Diabetes is the main factor causing lower limb vascular disease, contributing to damage to the vascular endothelium and increasing the risk of amputation [5], [9]. The group of patients with diabetes combined with occlusive disease of the lower extremities has more serious symptoms with more severe clinical manifestations such as ulcers, necrosis with infection, and sepsis. However, Vietnam still does not have many studies on the results of endovascular intervention for lower limb artery occlusion in diabetic patients, which is why we surveyed the mid-term results of this intervention. Patients with chronic lower limb arterial occlusion with diabetes. Methods: Retrospective description of case series. Results: The study had a mean age of 72.3 ± 11.2 years; Men accounted for 65.2% of the sample. Rutherford classifications 4,5 and 6 accounted for 28.1%, 40.4%, and 23.6% of the sample, respectively. Multi-level lesions with the aortic-iliac have a TASC II A rate of 76.4%; The femoropopliteal floor has a TASC II A rate of 58.4%; The below-the-knee has a TASC II B rate, accounting for 24.7% of the sample. Balloon dilatation accounts for a high proportion of all levels; the aortic-iliac accounts for 80.9%; The femoropopliteal level accounts for 52.8%, and the below-the-knee level accounts for 40.5% of the sample. The technical success rate reached 94.4%. Complications include embolism, hematoma, stent fracture, major amputation, myocardial infarction, and acute renal failure, accounting for 2.3% respectively, 2.3%, 1.1%, 1.1%, 2.3%, and 3.4% of the sample. At medium-term follow-up, the rate of head vascular circulation was 79.1%, significant major amputation was 18.6%, and stroke rate was 10.5% of the sample. Conclusion: Interventional methods to treat lower limb artery occlusion in diabetic patients have shown positive results, improved clinical symptoms, a medium-term primary patency revascularization rate, and few follow-up complications.